What is ELV's five-year median EV/Sales?

The median, or middle weekly reading, is 0.6× over the last five years. Available history contains 860 weekly observations from May 3, 2010 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Elevance Health (ELV) valuation history

Below its usual range

As of Oct 22, 2026

ELV's EV/Sales of 0.5x is lower than 71% of its available weekly readings from the last five years.

Share EV/Sales history

Shared chart range

Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/Sales at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

ELV year-end valuation history
Reading date	EV/Sales	5-year rank
Dec 29, 2025	0.4×	8%
Dec 30, 2024	0.4×	1%
Dec 25, 2023	0.6×	14%
Dec 26, 2022	0.7×	72%
Dec 27, 2021	0.8×	93%
Dec 28, 2020	0.6×	63%
Dec 30, 2019	0.7×	82%
Dec 31, 2018	0.7×	90%
Dec 25, 2017	0.6×	99%
Dec 26, 2016	0.4×	68%

Peers on the same measure

Stock	EV/Sales	5-year rank
CNCCentene Corporation	0.1×	22%
HUMHumana	0.3×	52%
AAgilent Technologies	7.1×	94%
ABBVAbbVie	8.7×	100%

Appears in

Health Care Stocks with Low P/E Ratios and Steady Revenue Growth Stocks Below Their 5-Year Median P/E Stocks Near Their Lowest P/E Ratios in 5 Years

Research on ELV

No published research on ELV yet. Read how valuation percentiles work.

Loading related research…

About this history

What is ELV's current EV/Sales?: ELV's EV/Sales of 0.5x is lower than 71% of its available weekly readings from the last five years.
What is ELV's five-year median EV/Sales?: The median, or middle weekly reading, is 0.6× over the last five years. Available history contains 860 weekly observations from May 3, 2010 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.